Status:
UNKNOWN
The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons
Lead Sponsor:
Herlev Hospital
Conditions:
Interaction Between the GH/IGF-I System and the Immune-system
Eligibility:
All Genders
22-65 years
Phase:
NA
Brief Summary
Observations in patients with growth hormone (GH)-disturbances have suggested that GH/IGF-I might have anti-inflammatory effects. To elucidate this hypothesis the investigators have planned a study to...
Detailed Description
To investigate if administration of 3 weeks og GH (10-30 microgram/kg/day) and subsequent Pegvisomant (10-15 mg/day) influence serum concentrations of the inflammatory variables Tumor Necrosis Factor ...
Eligibility Criteria
Inclusion
- Healthy, normal blood tests
Exclusion
- Previous cancer
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00969644
Start Date
September 1 2009
End Date
March 1 2010
Last Update
September 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology J 106, Herlev Hospital
Herlev, Herlev, Denmark, 2730